New therapies targeting aging cells in the skin




skin, senescence, aging, senolytics, fisetin, dasatinib, quercetin


Senescence is accompanied by numerous processes that lead to alterations in cell metabolism, cell cycle arrest, and, increased production and secretion of senescence-associated secretory phenotype (SASP). Consequently, signaling pathways cascades are activated, leading to inflammation that can trigger multiple disorders, including cancer. Recently, a novel therapeutic approach was proposed based on targeting senescent cells using senolytics. This group of biologically active compounds includes fisetin, quercetin, dasatinib, and others. These compounds were shown to affect laboratory animals (rodents) by improving the quality of life and significantly increasing the length of life by reducing senescent cells pool in different organs. Based on these findings, we decided to evaluate the potential of these compounds in targeting senescent cells in human skin using in vitro model based on human-derived keratinocytes (HEKa) and fibroblasts (HDFa). Cytotoxicity assay revealed that the activity of the compounds was time- and dose-dependent as well as cell-type dependent. Further studies were performed to reveal the mechanistic aspect of these observations including assessment of the senescence marker, namely p16. However, it requires clarification before entering clinical trials to provide not only efficient but, first of all, safe application of senolytics to human skin.


Download data is not yet available.


Dańczak-Pazdrowska A, Gornowicz-Porowska J, Polańska A, Krajka-Kuźniak V, Stawny M, Gostyńska A, Rubiś B, Nourredine S, Ashiqueali S, Schneider A, Tchkonia T, Wyles SP, Kirkland JL, Masternak MM. Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents. Aging Cell. 2023 Jun;22(6):e13845. doi: 10.1111/acel.13845. PMID: 37042069. DOI:

Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nat Med. 2022 Aug;28(8):1556-1568. doi: 10.1038/s41591-022-01923-y. PMID: 35953721. DOI:

Domaszewska-Szostek A, Puzianowska-Kuźnicka M, Kuryłowicz A. Flavonoids in Skin Senescence Prevention and Treatment. Int J Mol Sci. 2021 Jun 25;22(13):6814. doi: 10.3390/ijms22136814. PMID: 34201952. DOI:

Wu P.-Y., Lyu J.-L., Liu Y.-J., Chien T.-Y., Hsu H.-C., Wen K.-C., Chiang H.-M. Fisetin Regulates Nrf2 Expression and the Inflammation-Related Signaling Pathway to Prevent UVB-Induced Skin Damage in Hairless Mice. Int. J. Mol. Sci. 2017;18:2118. doi: 10.3390/ijms18102118. PMID: 28994699. DOI:

Kim S.-Y., Kim S.-J., Lee J.-Y., Kim W.-G., Park W.-S., Sim Y.-C., Lee S.-J. Protective effects of dietary soy isoflavones against UV-induced skin-aging in hairless mouse model. J. Am. Coll. Nutr. 2004;23:157–162. doi: 10.1080/07315724.2004.10719356. PMID: 15047682. DOI:

Kroma A, Feliczak-Guzik A, Pawlaczyk M, Osmałek T, Urbańska M, Micek I, Nawrot J, Gornowicz-Porowska J. Analysis of Cosmetic Products Containing Serratula coronata Herb Extract. Cosmetics. 2023; 10(1):18. DOI:

Romaniuk-Drapała A, Totoń E, Konieczna N, Machnik M, Barczak W, Kowal D, Kopczyński P, Kaczmarek M, Rubiś B. hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells. Cells. 2021 Apr 10;10(4):867. doi: 10.3390/cells10040867. PMID: 33920284; PMCID: PMC8068966. DOI:

Hense JD, Garcia DN, Isola JV, Alvarado-Rincón JA, Zanini BM, Prosczek JB, Stout MB, Mason JB, Walsh PT, Brieño-Enríquez MA, Schadock I, Barros CC, Masternak MM, Schneider A. Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary. Geroscience. 2022 Jun;44(3):1747-1759. doi: 10.1007/s11357-022-00573-9. Epub 2022 Apr 23. PMID: 35460445. DOI:

Chen J, Sivan U, Tan SL, Lippo L, De Angelis J, Labella R, Singh A, Chatzis A, Cheuk S, Medhghalchi M, Gil J, Hollander G, Marsden BD, Williams R, Ramasamy SK, Kusumbe AP. High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci Adv. 2021 Feb 3;7(6):eabd7819. doi: 10.1126/sciadv.abd7819. PMID: 33536212. DOI:

Nambiar A, Kellogg D 3rd, Justice J, Goros M, Gelfond J, Pascual R, Hashmi S, Masternak M, Prata L, LeBrasseur N, Limper A, Kritchevsky S, Musi N, Tchkonia T, Kirkland J. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. EBioMedicine. 2023 Apr;90:104481. doi: 10.1016/j.ebiom.2023.104481. PMID: 36857968. DOI:

Aboushanab AR, El-Moslemany RM, El-Kamel AH, Mehanna RA, Bakr BA, Ashour AA. Targeted Fisetin-Encapsulated β-Cyclodextrin Nanosponges for Breast Cancer. Pharmaceutics. 2023 May 12;15(5):1480. doi: 10.3390/pharmaceutics15051480. PMID: 37242722; PMCID: PMC10223291. DOI:

Ijima S, Saito Y, Nagaoka K, Yamamoto S, Sato T, Miura N, Iwamoto T, Miyajima M, Chikenji TS. Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis. Front Immunol. 2022 Nov 17;13:960601. doi: 10.3389/fimmu.2022.960601. PMID: 36466895. DOI:






Original Papers

How to Cite

Paszel-Jaworska A, Gornowicz-Porowska J, Dańczak-Pazdrowska A, Polańska A, Krajka-Kuźniak V, Stawny M, et al. New therapies targeting aging cells in the skin. JMS [Internet]. 2023 Sep. 29 [cited 2024 Jul. 19];92(3):e903. Available from:
Received 2023-08-01
Accepted 2023-09-09
Published 2023-09-29